Trials / Completed
CompletedNCT00381264
Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Multiple Sclerosis
A Multicenter Trial Evaluating the Efficacy of Cesamet™ for the Symptomatic Treatment of Pain in Patients With Multiple Sclerosis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 23 (estimated)
- Sponsor
- NEMA Research, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study was designed to evaluate the safety and efficacy of Cesamet™ in controlling pain in subjects experiencing pain due to Multiple Sclerosis.
Detailed description
The purpose of this study is to determine the safety and efficacy of Cesamet™ in the symptomatic treatment of pain due to Multiple Sclerosis. This is a phase IV, multi-center, open label outpatient clinical trial evaluating Cesamet™ treatment for control of pain due MS. The study has two phases: a Pretreatment Phase and a Treatment Phase.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cesamet™ (nabilone) |
Timeline
- Start date
- 2006-09-01
- Primary completion
- 2007-10-01
- Completion
- 2007-10-01
- First posted
- 2006-09-27
- Last updated
- 2008-02-15
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00381264. Inclusion in this directory is not an endorsement.